Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportGU

PSMA PET tumor-to-Salivary Glands ratio (PSG score) to predict response to Lu-177 PSMA radioligand therapy: an international multicenter retrospective study

Masatoshi Hotta, Andrei Gafita, Vishnu Murthy, Matthias Benz, Ida Sonni, Irene Burger, Matthias Eiber, Louise Emmett, Andrea Farolfi, Wolfgang Fendler, Michael Hofman, Thomas Hope, Clemens Kratochwil, Johannes Czernin and Jeremie Calais
Journal of Nuclear Medicine August 2022, 63 (supplement 2) 3040;
Masatoshi Hotta
1University of California Los Angeles
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrei Gafita
2UCLA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vishnu Murthy
3David Geffen School of Medicine at UCLA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthias Benz
4University of California, Los Angeles
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ida Sonni
4University of California, Los Angeles
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Irene Burger
5University Hospital Zurich
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthias Eiber
6Technical University Munich
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Louise Emmett
7Department of Theranostics and Nuclear Medicine, St Vincent’s Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrea Farolfi
8IRCCS Azienda Ospedaliero-Universitaria di Bologna
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wolfgang Fendler
9University Hospital Essen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Hofman
10Peter MacCallum Cancer Centre and University of Melbourne
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Hope
11University of California San Francisco
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Clemens Kratochwil
12University Hospital Heidelberg
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Johannes Czernin
13Ahmanson Translational Theranostics Division, Pharmacology, University of California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeremie Calais
4University of California, Los Angeles
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Article Information

vol. 63 no. supplement 2 3040

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online August 8, 2022.

Copyright & Usage 
© 2022

Author Information

  1. Masatoshi Hotta1,
  2. Andrei Gafita2,
  3. Vishnu Murthy3,
  4. Matthias Benz4,
  5. Ida Sonni4,
  6. Irene Burger5,
  7. Matthias Eiber6,
  8. Louise Emmett7,
  9. Andrea Farolfi8,
  10. Wolfgang Fendler9,
  11. Michael Hofman10,
  12. Thomas Hope11,
  13. Clemens Kratochwil12,
  14. Johannes Czernin13 and
  15. Jeremie Calais4
  1. 1University of California Los Angeles
  2. 2UCLA
  3. 3David Geffen School of Medicine at UCLA
  4. 4University of California, Los Angeles
  5. 5University Hospital Zurich
  6. 6Technical University Munich
  7. 7Department of Theranostics and Nuclear Medicine, St Vincent’s Hospital
  8. 8IRCCS Azienda Ospedaliero-Universitaria di Bologna
  9. 9University Hospital Essen
  10. 10Peter MacCallum Cancer Centre and University of Melbourne
  11. 11University of California San Francisco
  12. 12University Hospital Heidelberg
  13. 13Ahmanson Translational Theranostics Division, Pharmacology, University of California

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: August 2022 to April 2025

AbstractFullPdf
Aug 20222600
Sep 20223300
Oct 20221900
Nov 20221300
Dec 20221500
Jan 20232700
Feb 20232300
Mar 20232000
Apr 20235700
May 20234200
Jun 20233300
Jul 20233700
Aug 20231300
Sep 20231000
Oct 20231600
Nov 20231800
Dec 20231800
Jan 20242000
Feb 2024800
Mar 20241700
Apr 20245100
May 20242500
Jun 20244100
Jul 202412400
Aug 20249700
Sep 20244000
Oct 20242100
Nov 20241800
Dec 20241200
Jan 2025400
Feb 20251300
Mar 20251500
Apr 20252300
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 63, Issue supplement 2
August 1, 2022
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
PSMA PET tumor-to-Salivary Glands ratio (PSG score) to predict response to Lu-177 PSMA radioligand therapy: an international multicenter retrospective study
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
PSMA PET tumor-to-Salivary Glands ratio (PSG score) to predict response to Lu-177 PSMA radioligand therapy: an international multicenter retrospective study
Masatoshi Hotta, Andrei Gafita, Vishnu Murthy, Matthias Benz, Ida Sonni, Irene Burger, Matthias Eiber, Louise Emmett, Andrea Farolfi, Wolfgang Fendler, Michael Hofman, Thomas Hope, Clemens Kratochwil, Johannes Czernin, Jeremie Calais
Journal of Nuclear Medicine Aug 2022, 63 (supplement 2) 3040;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
PSMA PET tumor-to-Salivary Glands ratio (PSG score) to predict response to Lu-177 PSMA radioligand therapy: an international multicenter retrospective study
Masatoshi Hotta, Andrei Gafita, Vishnu Murthy, Matthias Benz, Ida Sonni, Irene Burger, Matthias Eiber, Louise Emmett, Andrea Farolfi, Wolfgang Fendler, Michael Hofman, Thomas Hope, Clemens Kratochwil, Johannes Czernin, Jeremie Calais
Journal of Nuclear Medicine Aug 2022, 63 (supplement 2) 3040;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Semi-automatic Segmentation of Metastatic Tumor Load for 177Lu-PSMA Therapy
  • [68Ga]-PSMA-11 can clarify equivocal lesions on conventional imaging and change management decisions among men with previously treated prostate cancer
  • Can primary PET/CT staging using [68Ga]Ga-RM2 and [18F]Choline predict recurrence in prostate cancer?
Show more GU

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire